Regulatory
Part:BBa_K2624000:Experience
Designed by: Yunge Lou, Yali Wu Group: iGEM18_CPU_CHINA (2018-08-22)
Revision as of 20:17, 17 October 2018 by JunQing Flag (Talk | contribs) (→Applications of BBa_K2624000)
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K2624000
To improve the selectivity of our therapy system, we utilize hTERT, the cancer-specific promoter, and HULC, the HCC-specific promoter, to open an AND-gated system to target HCC (Hepatocellular carcinoma). pGL3-Basic vector, a promoterless vector is used for measuring the activity of promoter with a luciferase assay. We determined the activity of the two promoters by it. Experimental results show that the promoter has a good startup efficiency,although the efficiency is lower than CMV promoter.
"
"
User Reviews
UNIQ8c7b8ce2487c0872-partinfo-00000000-QINU UNIQ8c7b8ce2487c0872-partinfo-00000001-QINU